COMPANY

Invea Therapeutics

HQ: Guilford, CT source · inveatx.com ↗ · New England

Keywords: immunology inflammatory diseases small molecule

Location: Guilford, CT · source · Oct 14, 2026

Profile checked Oct 10, 2026

Raises and investors new

Form D raises come from the company’s own SEC filing (last 2 years).

2025-12-10 Raise Private raise (SEC Form D): $120K sold; issuer “Invea Therapeutics, Inc”. Verified from the SEC filing. SEC filing ↗
2025-04-09 Raise Private raise (SEC Form D): $300K sold of $600K offered; issuer “Invea Therapeutics, Inc”. Verified from the SEC filing. SEC filing ↗

SEC Form D raise Raised $120K (Form D filed Dec 10, 2025). SEC Form D 0001906425-25-000004 (Dec 10, 2025)
Evidence (1 event)
- Dec 10, 2025 · SEC Form D 0001906425-25-000004
  Name of Issuer: Invea Therapeutics, Inc; CIK: 1906425; Address: Guilford, CT; Submission type: D; Filing date: 2025-12-10; Industry Group: Biotechnology; Date of First Sale: 2025-10-31; Types of Securities Offered: Equity, Option/warrant; Business combination transaction: false; Total Offering Amount: 120250; Total Amount Sold: 120250; Federal exemptions: 06b

Job counts as of Oct 18, 2026. All funding and NIH signals